1997Current Opinion in HematologyRequires access

Scavenger receptors in atherosclerosis

Mason W. Freeman

Open publisher page 51 citations

Abstract

Membership in the broad family of scavenger receptors has grown significantly. Two new scavenger receptor receptors have been cloned (SR-BI and SR-CI) and a previously isolated integral membrane protein (CD36) has been found to possess lipoprotein binding properties that entitle it to be included in the family. The breadth of ligand recognition of this class of receptors has also increased with the discovery that high-density lipoproteins and anionic phospholipids can bind to scavenger receptors. New studies linking these receptors to apoptotic and signal transduction pathways have further enlarged their potential contributions to normal immune function as well as the process of atherosclerosis. Clarifying the physiologic as well as pathophysiologic significance of these multifunctional proteins has proven challenging, but mouse homologous recombination technology will soon yield critical insights into the role scavenger receptors play in atherosclerosis and other macrophage-associated immune functions.

About this research paper

What this paper is about

Membership in the broad family of scavenger receptors has grown significantly. Two new scavenger receptor receptors have been cloned (SR-BI and SR-CI) and a previously isolated integral membrane protein (CD36) has been found to possess lipoprotein binding properties that entitle it to be included in the family. The breadth of ligand recognition of this class of receptors has also increased with the discovery that high-density lipoproteins and anionic phospholipids can bind to scavenger receptors. New studies linking these receptors to apoptotic and signal transduction pathways have further enlarged their potential contributions to normal immune function as well as the process of atherosclerosis. Clarifying the physiologic as well as pathophysiologic significance of these multifunctional proteins has proven challenging, but mouse homologous recombination technology will soon yield critical insights into the role scavenger receptors play in atherosclerosis and other macrophage-associated immune functions.

Why it matters

OpenAlex reports 51 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Membership in the broad family of scavenger receptors has grown significantly. Two new scavenger receptor receptors have been cloned (SR-BI and SR-CI) and a previously isolated integral membrane protein (CD36) has been found to possess lipoprotein binding properties that entitle it to be included in the family. The breadth of ligand recognition of this class of receptors has also increased with the discovery that high-density lipoproteins and anionic phospholipids can bind to scavenger receptors. New studies linking these receptors to apoptotic and signal transduction pathways have further enlarged their potential contributions to normal immune function as well as the process of atherosclerosis. Clarifying the physiologic as well as pathophysiologic significance of these multifunctional proteins has proven challenging, but mouse homologous recombination technology will soon yield critical insights into the role scavenger receptors play in atherosclerosis and other macrophage-associated immune functions.

Key concepts: Scavenger receptor, CD36, Receptor, Cell biology, Signal transduction, Biology, Immune system, Immune receptor

Related papers

Back to paper searchBrowse research topicsOriginal source
Scavenger receptors in atherosclerosis — Research Paper | ScholarLens